Takeda Hid Gout, GERD Drug Interactions: Whistleblower

By Roxanne Palmer · January 25, 2012, 7:50 PM EST

Takeda Pharmaceutical Co. Ltd. purposely concealed unsafe drug interactions in three treatments for gout and heartburn, causing state and federal governments to overpay for drugs, a former Takeda contractor alleged Wednesday...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

United States of America et al v. Takeda Pharmaceutical Company Limited, et al

Case Number

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

March 01, 2011

Recent Articles By Roxanne

March 13, 2012
Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
February 29, 2012
3rd Circ. Says AIG Unit Doesn't Owe Hospital Group Coverage
February 22, 2012
Wash.'s Contraceptive Sales Rules Unconstitutional: Judge
February 15, 2012
Calif. High Court Takes Up Cipro Pay-For-Delay Suit
February 07, 2012
Illumina Board Urges Investors To Reject $6B Roche Bid
February 03, 2012
FTC Won't Get Monitor For ProMedica Hospital Operations
December 21, 2011
NY Court Sets Test For Summary Judgment In Bias Cases
December 16, 2011
HHS To Let States Set Benefit Benchmarks For Health Plans
December 06, 2011
Pfizer Hit With $73M Verdict In Menopause Drug Suit
November 30, 2011
Investors Sue Abbott Over $1.5B Depakote Settlement Tab